<p>Pranlukast Antagonizes CD49f and Reduces Stemness in Triple-Negative Breast Cancer Cells</p>-Reference-Cited by-同舟云学术

Pranlukast Antagonizes CD49f and Reduces Stemness in Triple-Negative Breast Cancer Cells

Published:2020-05 Issue: Volume:Volume 14 Page:1799-1811
ISSN:1177-8881
Container-title:Drug Design, Development and Therapy
language:en
Short-container-title:DDDT

Author:

Velázquez-Quesada Inés,Ruiz-Moreno Angel J^ORCID,Casique-Aguirre Diana^ORCID,Aguirre-Alvarado Charmina,Cortés-Mendoza Fabiola,de la Fuente-Granada Marisol,García-Pérez Carlos,Pérez-Tapia Sonia M^ORCID,González-Arenas Aliesha^ORCID,Segura-Cabrera Aldo,Velasco-Velázquez Marco A^ORCID

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

Reference75 articles.

1. Stewart B, Wild CP World Cancer Report 2014. Lyon, France: International Agency for Research on Cancer; 2014.

2. Population Reference Bureau. 2012 World Population Data Sheet. Population Reference Bureau. ed.. Washington, DC: Population Reference Bureau; 2012.

3. Pathways to Breast Cancer Recurrence

4. Breast cancer stem cells

5. Regulation of Laminin 1-Induced Pancreatic β-Cell Differentiation by α6 Integrin and α-Dystroglycan

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug repurposing: a retrospective revolution in breast cancer medicine;Discover Medicine;2024-07-12

2. Cancer stem cells: advances in knowledge and implications for cancer therapy;Signal Transduction and Targeted Therapy;2024-07-05

3. In silico approaches for drug repurposing in oncology: a scoping review;Frontiers in Pharmacology;2024-06-11

4. Impact of brain organoid-derived sEVs on metastatic adaptation and invasion of breast carcinoma cells through a microphysiological system;Lab on a Chip;2024

5. Preclinical and Clinical Trials of New Treatment Strategies Targeting Cancer Stem Cells in Subtypes of Breast Cancer;Cells;2023-02-24